These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33320836)

  • 1. The MUC5B-associated variant rs35705950 resides within an enhancer subject to lineage- and disease-dependent epigenetic remodeling.
    Gally F; Sasse SK; Kurche JS; Gruca MA; Cardwell JH; Okamoto T; Chu HW; Hou X; Poirion OB; Buchanan J; Preissl S; Ren B; Colgan SP; Dowell RD; Yang IV; Schwartz DA; Gerber AN
    JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33320836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis.
    Helling BA; Gerber AN; Kadiyala V; Sasse SK; Pedersen BS; Sparks L; Nakano Y; Okamoto T; Evans CM; Yang IV; Schwartz DA
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):91-99. PubMed ID: 28272906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
    Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
    Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between the promoter
    Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
    Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
    Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
    Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.
    Okamoto T; Mathai SK; Hennessy CE; Hancock LA; Walts AD; Stefanski AL; Brown KK; Lynch DA; Cosgrove GP; Groshong SD; Cool CD; Schwarz MI; Banda NK; Thurman JM; Yang IV; Holers VM; Schwartz DA
    Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L1-L10. PubMed ID: 29565179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.
    Schwartz DA
    Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S192-S197. PubMed ID: 30431344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human
    Tharavecharak S; Fujimoto H; Yasuma T; D'Alessandro-Gabazza CN; Toda M; Tomaru A; Saiki H; Uemura M; Kogue Y; Ito T; Furuhashi K; Okano T; Takeshita A; Nishihama K; Ono R; Hataji O; Nosaka T; Kobayashi T; Gabazza EC
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia.
    Chen G; Ribeiro CMP; Sun L; Okuda K; Kato T; Gilmore RC; Martino MB; Dang H; Abzhanova A; Lin JM; Hull-Ryde EA; Volmer AS; Randell SH; Livraghi-Butrico A; Deng Y; Scherer PE; Stripp BR; O'Neal WK; Boucher RC
    Am J Respir Crit Care Med; 2019 Jul; 200(2):220-234. PubMed ID: 30973754
    [No Abstract]   [Full Text] [Related]  

  • 11. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.
    Wu X; Li W; Luo Z; Chen Y
    Sci Rep; 2021 Dec; 11(1):24007. PubMed ID: 34907291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
    Fadista J; Kraven LM; Karjalainen J; Andrews SJ; Geller F; ; Baillie JK; Wain LV; Jenkins RG; Feenstra B
    EBioMedicine; 2021 Mar; 65():103277. PubMed ID: 33714028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
    Lee MG; Lee YH
    Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
    Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
    Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF.
    Bonella F; Campo I; Zorzetto M; Boerner E; Ohshimo S; Theegarten D; Taube C; Costabel U
    Orphanet J Rare Dis; 2021 Feb; 16(1):111. PubMed ID: 33639995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice.
    Hancock LA; Hennessy CE; Solomon GM; Dobrinskikh E; Estrella A; Hara N; Hill DB; Kissner WJ; Markovetz MR; Grove Villalon DE; Voss ME; Tearney GJ; Carroll KS; Shi Y; Schwarz MI; Thelin WR; Rowe SM; Yang IV; Evans CM; Schwartz DA
    Nat Commun; 2018 Dec; 9(1):5363. PubMed ID: 30560893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering
    Zhang Q; Wang Y; Qu D; Yu J; Yang J
    Biomed Res Int; 2019; 2019():9712464. PubMed ID: 31309122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants Supports Functional Roles of
    Borie R; Cardwell J; Konigsberg IR; Moore CM; Zhang W; Sasse SK; Gally F; Dobrinskikh E; Walts A; Powers J; Brancato J; Rojas M; Wolters PJ; Brown KK; Blackwell TS; Nakanishi T; Richards JB; Gerber AN; Fingerlin TE; Sachs N; Pulit SL; Zappala Z; Schwartz DA; Yang IV
    Am J Respir Crit Care Med; 2022 Nov; 206(10):1259-1270. PubMed ID: 35816432
    [No Abstract]   [Full Text] [Related]  

  • 20. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
    van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM
    Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.